Abstract
Background
This trial was undertaken to assess the efficacy of a multimodality management regime used for the prevention of hypertrophic scars. It follows previous research and experience (A.D. Widgerow et al, Aesthetic Plast Surg, 24(3):227–234, 2000) with a similar program but with the addition of active agents with specific effects against prolonged inflammation and enhanced hydrative capacity. The modalities specifically targeted are tension on the scar, hydration of the scar, collagen maturation, and controlled inflammation.
Methods
Tape was impregnated with a combination of agents providing an occlusive dressing aimed at combatting exaggerated scarring. Patients who had undergone surgery were stratified into four groups: Group 1, 60 patients/60 scars following simple skin excisions, 30 treated scars, 30 untreated scars; Group 2, 20 patients/40 scars, each patient with two excisions, one treated, one untreated; Group 3, 10 patients/20 scars following bilateral breast surgery, one side treated with tape alone, one side treated with tape and gel; Group 4, 30 patients with varying cosmetic procedures/50 scars, all treated and compared with historical outcomes for hypertrophic scarring. Thus, 170 scars were assessed in 120 patients.
Results
Results were assessed at 1, 2, and 6 months using a combination of accepted scar assessment techniques. By amalgamating the Vancouver, Manchester, and morphologic table systems together with Patient and Observer Scar Assessment analyses, a comprehensive assessment of scar outcomes was undertaken and comparisons were made with control groups.
Conclusion
Treated groups showed improvement outcomes in all variations of assessment. Patient and observer assessments correlated well, and morphologic appearances of the scars following the final assessment at 6 months showed statistically significant positive scar outcomes in the treatment groups. The multimodality approach to scar control showed significant benefits in the patient groups tested in this series.
Similar content being viewed by others
References
Widgerow AD, Chait LA, Stals R, Stals PJ (2000) New innovations in scar management. Aesthetic Plast Surg 24(3):227–234
Meyer M, McGrouther DA (1991) A study relating wound tension to scar morphology in the presternal scar using Langers technique. Br J Plast Surg 44(4):291–294
Murison M, James W (2006) Preliminary evaluation of the efficacy of Dermatix silicone gel in the reduction of scar elevation and pigmentation. J Plast Reconstr Aesthet Surg 59(4):437–439
Atkinson JM, McKenna KT, Barnett AG, McGrath DJ, Rudd M (2005) A randomized, controlled trial to determine the efficacy of paper tape in preventing hypertrophic scar formation in surgical incisions that traverse Langer’s skin tension lines. Plast Reconstr Surg 116(6):1648–1656
Petroni A, Blasevich M, Salami M, Papini N, Montedoro GF, Galli C (1995) Inhibition of platelet aggregation and eicosanoid production by phenolic components of olive oil. Thrombosis Res 78(2):151–160
Sawada Y, Sone K (1992) Hydration and occlusion treatment for hypertrophic scars and keloids. Br J Plast Surg 45(8):599–603
Soderberg J (1982) Treatment of keloids and hypertrophic scars with adhesive zinc tape. Scand J Plast Surg 16:261
Chang CC, Kuo YF, Chiu HC, Lee JL, Wong TW, Jee SH (1995) Hydration, not silicone, modulates the effects of keratinocytes on fibroblasts. J Surg Res 59(6):705–711
Shah M, Foreman DM, Ferguson MW (1994) Neutralising antibody to TGF-beta 1, 2 reduces cutaneous scarring in adult rodents. J Cell Sci 107(5):1137–1157
Atiyeh BS (2007) Nonsurgical management of hypertrophic scars: evidence-based therapies, standard practices, and emerging methods. Aesthetic Plast Surg 31(5):468–492
Hertog MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D (1993) Dietary antioxidant flavonoids and risk of coronary heart disease: the Zupthen Elderly Study. Lancet 342(8878):1007–1011
Powers PS, Sarkar S, Goldgof DB, Cruse CW, Tsap LV (1999) Scar assessment: current problems and future solutions. J Burn Care Rehabil 20(1 Pt 1):54–60
Beauchamp GK, Keast RS, Morel D, Lin J, Pika J, Han Q, Lee CH, Smith AB, Breslin PA (2005) Phytochemistry: ibuprofen-like activity in extra-virgin olive oil. Nature 437(7055):45–46
de la Puerta R, Martinez-Dominguez E, Ruiz-Gutiérrez V (2000) Effect of minor components of virgin olive oil on topical anti-inflammatory assays. Z Naturforsch [C] 55(9–10):814–819
Tranter HS, Tassou SC, Nychas GJ (1993) The effect of the olive phenolic compound, oleuropein, on growth and enterotoxin B production by Staphylococcus aureus. J Appl Bacteriol 74(3):253–259
Mustoe TA (2008) Evolution of silicone therapy and mechanism of action in scar management. Aesthetic Plast Surg 32(1):82–92
Niessen FB (1997) Effectiveness of silicone sheets in the prevention of hypertrophic breast scars. Ann Plast Surg 38(5):547 (letter)
Reiffel R (1995) Prevention of hypertrophic scars by long term use of paper tape application. Plast Reconstr Surg 96(7):171–175
Signorini M, Clementoni MT (2007) Clinical evaluation of a new self-drying silicone gel in the treatment of scars: a preliminary report. Aesthetic Plast Surg 31(2):183–187
Baryza MJ, Baryza GA (1995) The Vancouver Scar Scale: an administration tool and its interrater reliability. J Burn Care Rehabil 16(5):535–538
Draaijers LJ, Tempelman FR, Botman YA, Tuinebreijer WE, Middelkoop E, Kreis RW, van Zuijlen PP (2004) The patient and observer scar assessment scale: a reliable and feasible tool for scar evaluation. Plast Reconstr Surg 113(7):1960–1965
Puig A, Anton GM, Mangues M (2007) A new decorin-like tetrapeptide for optimal organization of collagen fibres. IFSCC Mag 10(4):309
Truong PT, Lee JC, Soer B, Gaul CA, Olivotto IA (2007) Reliability and validity testing of the Patient and Observer Scar Assessment Scale in evaluating linear scars after breast cancer surgery. Plast Reconstr Surg 119(2):487–494
Ono I, Akasaka Y, Kikuchi R, Sakemoto A, Kamiya T, Yamashita T, Jimbow K (2007) Basic fibroblast growth factor reduces scar formation in acute incisional wounds. Wound Repair Regen 15(5):617–623
Wilgus TA, Vodovotz Y, Vittadini E, Clubbs E, Oberyszyn T (2003) Reduction of scar formation in full-thickness wounds with topical celecoxib treatment. Wound Repair Regen 11(1):25–34
Chen WY, Rogers AA (2007) Recent insights into the causes of chronic leg ulceration in venous diseases and implications on other types of chronic wounds. Wound Repair Regen 15(4):434–449
van Wyk BE, Van Oudtshoorn B, Gericke N (1997) Medicinal plants of South Africa. Briza Publications, Arcadia, South Africa, p 64
Mustoe TA, Cooter RD, Gold MH, Hobbs FD, Ramelet AA, Shakespeare PG, Stella M, Téot L, Wood FM, Ziegler UE (2002) International Advisory Panel on Scar Management. International clinical recommendations on scar management. Plast Reconstr Surg 110(2):560–571 (review)
Author information
Authors and Affiliations
Corresponding author
Additional information
A. D. Widgerow and L. A. Chait are consultants to Biovac (South Africa).
Rights and permissions
About this article
Cite this article
Widgerow, A.D., Chait, L.A., Stals, P.J. et al. Multimodality Scar Management Program. Aesth Plast Surg 33, 533–543 (2009). https://doi.org/10.1007/s00266-008-9276-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00266-008-9276-x